Polidocanol Ablation in Midventricular Obstructive Cardiomyopathy: Novel Approach and Early Outcomes
Polidocanol ablation was safe and effective as a minimally invasive option for managing MVOHCM, providing noteworthy procedural advantages. However, additional multicenter trials are needed to validate its use and establish standardized protocols.
Authors
- Kudret Aytemir (ORCID: https://orcid.org/0000-0001-9279-8424)
- Necla Özer (ORCID: https://orcid.org/0000-0001-7914-0169)
- Uğur Canpolat (ORCID: https://orcid.org/0000-0002-4250-1706)
- Cem Çöteli (ORCID: https://orcid.org/0000-0001-5520-7103)
- L. Şahiner (ORCID: https://orcid.org/0000-0002-0985-3144)
- Ahmet Kıvrak (ORCID: https://orcid.org/0000-0001-5232-8436)
- Mert Doğan (ORCID: https://orcid.org/0000-0002-2965-058X)
- Can Menemencioğlu (ORCID: https://orcid.org/0000-0001-6762-1280)
- Ahmet Hakan Ateş (ORCID: https://orcid.org/0000-0001-5414-7268)
- Ergün Barış Kaya (ORCID: https://orcid.org/0000-0002-4424-3704)
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- The Journal of invasive cardiology/The journal of invasive cardiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.25270/jic/25.00035
- Citations
- 1
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39